Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

New agents for HIV infection presented by Gilead Sciences

Jan. 28, 2013

Gilead initiates phase III program for tenofovir alafenamide in HIV

Jan. 25, 2013

European approval for new 800-mg tablet of Prezista

Jan. 16, 2013

GeoVax completes enrollment in phase I/II trial for HIV/AIDS vaccine

Jan. 14, 2013

Tobira Therapeutics reports data from phase IIb cenicriviroc trial

Jan. 10, 2013

Takara Bio begins phase I trial of HIV-1 gene therapy

Jan. 10, 2013

Clinical evaluation of the safety and tolerability of HIV vaccine alternative

Jan. 8, 2013

Novel HIV vaccine adjuvants created by French investigators

Jan. 7, 2013

ViiV Healthcare files for approval of dolutegravir

Dec. 19, 2012

Biotron's BIT-225 completes proof-of-concept trial in HIV

Dec. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...